Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark T Heise

Showing results (1-10 of 133) with videos related to

Pageof 14
Sort By:
Current Opinion in Virology|June 17, 2014
Editorial overview: viral pathogenesis: dealing with complexity in virus-induced diseaseMark T Heise
Clinical Therapeutics|September 22, 2019
Mouse Models as Resources for Studying Infectious DiseasesSanjay Sarkar, Mark T Heise
Current Tropical Medicine Reports|September 15, 2015
Protective and Pathogenic Responses to Chikungunya Virus InfectionKristin M Long, Mark T Heise
The Journal of Infectious Diseases|June 19, 2012
Chikungunya virus transmission--more than meets the eyeKristin M Long, Mark T Heise
Mammalian Genome : Official Journal of the International Mammalian Genome Society|August 29, 2018
Genetic control of alphavirus pathogenesisVictoria K Baxter, Mark T Heise
Advances in Virus Research|July 27, 2020
Immunopathogenesis of alphavirusesVictoria K Baxter, Mark T Heise
Advances in Virus Research|December 31, 2013
Quantitative genetics in the study of virus-induced diseaseMartin T Ferris, Mark T Heise
Plos Neglected Tropical Diseases|June 29, 2010
Vaccination with DNA plasmids expressing Gn coupled to C3d or alphavirus replicons expressing gn protects mice against Rift Valley fever virusNitin Bhardwaj, Mark T Heise, Ted M Ross
Journal of Virology|October 17, 2008
Ross River virus envelope glycans contribute to type I interferon production in myeloid dendritic cellsReed S Shabman, Kristin M Rogers, Mark T Heise
Journal of Virology|September 13, 2008
Complement receptor 3 promotes severe ross river virus-induced diseaseThomas E Morrison, Jason D Simmons, Mark T Heise
Pageof 14

Showing results (1-10 of 133) with videos related to

Sort By:
Pageof 14
Current Opinion in Virology|June 17, 2014
Editorial overview: viral pathogenesis: dealing with complexity in virus-induced diseaseMark T Heise
Clinical Therapeutics|September 22, 2019
Mouse Models as Resources for Studying Infectious DiseasesSanjay Sarkar, Mark T Heise
Current Tropical Medicine Reports|September 15, 2015
Protective and Pathogenic Responses to Chikungunya Virus InfectionKristin M Long, Mark T Heise
The Journal of Infectious Diseases|June 19, 2012
Chikungunya virus transmission--more than meets the eyeKristin M Long, Mark T Heise
Mammalian Genome : Official Journal of the International Mammalian Genome Society|August 29, 2018
Genetic control of alphavirus pathogenesisVictoria K Baxter, Mark T Heise
Advances in Virus Research|July 27, 2020
Immunopathogenesis of alphavirusesVictoria K Baxter, Mark T Heise
Advances in Virus Research|December 31, 2013
Quantitative genetics in the study of virus-induced diseaseMartin T Ferris, Mark T Heise
Plos Neglected Tropical Diseases|June 29, 2010
Vaccination with DNA plasmids expressing Gn coupled to C3d or alphavirus replicons expressing gn protects mice against Rift Valley fever virusNitin Bhardwaj, Mark T Heise, Ted M Ross
Journal of Virology|October 17, 2008
Ross River virus envelope glycans contribute to type I interferon production in myeloid dendritic cellsReed S Shabman, Kristin M Rogers, Mark T Heise
Journal of Virology|September 13, 2008
Complement receptor 3 promotes severe ross river virus-induced diseaseThomas E Morrison, Jason D Simmons, Mark T Heise
Pageof 14